179 related articles for article (PubMed ID: 26136337)
1. Radiosensitization and downregulation of heterogeneous nuclear ribonucleoprotein K (hnRNP K) upon inhibition of mitogen/extracellular signal-regulated kinase (MEK) in malignant melanoma cells.
Eder S; Lamkowski A; Priller M; Port M; Steinestel K
Oncotarget; 2015 Jul; 6(19):17178-91. PubMed ID: 26136337
[TBL] [Abstract][Full Text] [Related]
2. Baseline MAPK signaling activity confers intrinsic radioresistance to KRAS-mutant colorectal carcinoma cells by rapid upregulation of heterogeneous nuclear ribonucleoprotein K (hnRNP K).
Eder S; Arndt A; Lamkowski A; Daskalaki W; Rump A; Priller M; Genze F; Wardelmann E; Port M; Steinestel K
Cancer Lett; 2017 Jan; 385():160-167. PubMed ID: 27793696
[TBL] [Abstract][Full Text] [Related]
3. Higher expression of the heterogeneous nuclear ribonucleoprotein k in melanoma.
Wen F; Shen A; Shanas R; Bhattacharyya A; Lian F; Hostetter G; Shi J
Ann Surg Oncol; 2010 Oct; 17(10):2619-27. PubMed ID: 20499280
[TBL] [Abstract][Full Text] [Related]
4. Expression levels of hnRNP K and p21WAF1/CIP1 are associated with resistance to radiochemotherapy independent of p53 pathway activation in rectal adenocarcinoma.
Daskalaki W; Wardelmann E; Port M; Stock K; Steinestel J; Huss S; Sperveslage J; Steinestel K; Eder S
Int J Mol Med; 2018 Dec; 42(6):3269-3277. PubMed ID: 30272263
[TBL] [Abstract][Full Text] [Related]
5. Thymidine phosphorylase mRNA stability and protein levels are increased through ERK-mediated cytoplasmic accumulation of hnRNP K in nasopharyngeal carcinoma cells.
Chen LC; Liu HP; Li HP; Hsueh C; Yu JS; Liang CL; Chang YS
Oncogene; 2009 Apr; 28(17):1904-15. PubMed ID: 19330019
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53.
Zhou R; Shanas R; Nelson MA; Bhattacharyya A; Shi J
Int J Cancer; 2010 Jan; 126(2):395-404. PubMed ID: 19609950
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous nuclear ribonucleoprotein K is overexpressed and contributes to radioresistance irrespective of HPV status in head and neck squamous cell carcinoma.
Kähler J; Hafner S; Popp T; Hermann C; Rump A; Port M; Steinestel K; Eder S
Int J Mol Med; 2020 Nov; 46(5):1733-1742. PubMed ID: 32901844
[TBL] [Abstract][Full Text] [Related]
8. ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation.
Habelhah H; Shah K; Huang L; Ostareck-Lederer A; Burlingame AL; Shokat KM; Hentze MW; Ronai Z
Nat Cell Biol; 2001 Mar; 3(3):325-30. PubMed ID: 11231586
[TBL] [Abstract][Full Text] [Related]
9. hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage.
Moumen A; Masterson P; O'Connor MJ; Jackson SP
Cell; 2005 Dec; 123(6):1065-78. PubMed ID: 16360036
[TBL] [Abstract][Full Text] [Related]
10. hnRNP K suppresses apoptosis independent of p53 status by maintaining high levels of endogenous caspase inhibitors.
Xiao Z; Ko HL; Goh EH; Wang B; Ren EC
Carcinogenesis; 2013 Jul; 34(7):1458-67. PubMed ID: 23455382
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic Accumulation of Heterogeneous Nuclear Ribonucleoprotein K Strongly Promotes Tumor Invasion in Renal Cell Carcinoma Cells.
Otoshi T; Tanaka T; Morimoto K; Nakatani T
PLoS One; 2015; 10(12):e0145769. PubMed ID: 26713736
[TBL] [Abstract][Full Text] [Related]
12. Direct recruitment of ERK cascade components to inducible genes is regulated by heterogeneous nuclear ribonucleoprotein (hnRNP) K.
Mikula M; Bomsztyk K
J Biol Chem; 2011 Mar; 286(11):9763-75. PubMed ID: 21233203
[TBL] [Abstract][Full Text] [Related]
13. The antiapoptotic protein, FLIP, is regulated by heterogeneous nuclear ribonucleoprotein K and correlates with poor overall survival of nasopharyngeal carcinoma patients.
Chen LC; Chung IC; Hsueh C; Tsang NM; Chi LM; Liang Y; Chen CC; Wang LJ; Chang YS
Cell Death Differ; 2010 Sep; 17(9):1463-73. PubMed ID: 20224598
[TBL] [Abstract][Full Text] [Related]
14. hnRNP K plays a protective role in TNF-α-induced apoptosis in podocytes.
Zhao S; Feng J; Wang Q; Tian L; Zhang Y; Li H
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29724888
[TBL] [Abstract][Full Text] [Related]
15. Ras mediates radioresistance through both phosphatidylinositol 3-kinase-dependent and Raf-dependent but mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-independent signaling pathways.
Grana TM; Rusyn EV; Zhou H; Sartor CI; Cox AD
Cancer Res; 2002 Jul; 62(14):4142-50. PubMed ID: 12124353
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase C-delta mediates down-regulation of heterogeneous nuclear ribonucleoprotein K protein: involvement in apoptosis induction.
Gao FH; Wu YL; Zhao M; Liu CX; Wang LS; Chen GQ
Exp Cell Res; 2009 Nov; 315(19):3250-8. PubMed ID: 19747914
[TBL] [Abstract][Full Text] [Related]
17. hnRNP-K is a nuclear target of TCR-activated ERK and required for T-cell late activation.
Chang JW; Koike T; Iwashima M
Int Immunol; 2009 Dec; 21(12):1351-61. PubMed ID: 19880579
[TBL] [Abstract][Full Text] [Related]
18. MIG6 Is MEK Regulated and Affects EGF-Induced Migration in Mutant NRAS Melanoma.
Vu HL; Rosenbaum S; Capparelli C; Purwin TJ; Davies MA; Berger AC; Aplin AE
J Invest Dermatol; 2016 Feb; 136(2):453-463. PubMed ID: 26967478
[TBL] [Abstract][Full Text] [Related]
19. Suppression of oncogenic NRAS by RNA interference induces apoptosis of human melanoma cells.
Eskandarpour M; Kiaii S; Zhu C; Castro J; Sakko AJ; Hansson J
Int J Cancer; 2005 May; 115(1):65-73. PubMed ID: 15688405
[TBL] [Abstract][Full Text] [Related]
20. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.
Bucci B; D'Agnano I; Amendola D; Citti A; Raza GH; Miceli R; De Paula U; Marchese R; Albini S; Felsani A; Brunetti E; Vecchione A
Clin Cancer Res; 2005 Apr; 11(7):2756-67. PubMed ID: 15814658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
